Related Experiment Videos
Amoxapine failure--a neuroleptic property?
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|October 1, 1984
Summary
Amoxapine treatment for depression can fail, even after initial success. This may be due to dopamine-blocking effects of its metabolites, leading to severe deterioration or neuroleptic effects.
Area of Science:
- Pharmacology
- Neuroscience
- Psychiatry
Background:
- Amoxapine, a dibenzoxazepine antidepressant, was recently introduced for depression treatment.
- Loxapine is another drug in the same class.
Observation:
- Five cases of amoxapine treatment failure are presented.
- Patients initially responded well but deteriorated severely with dosage increases.
Findings:
- The study discusses the dopamine-blocking effects of amoxapine metabolites.
- Treatment failure may be linked to akinetic depression or potent neuroleptic effects.
Implications:
- Understanding amoxapine's metabolite effects is crucial for managing depression treatment.
- This highlights potential risks associated with amoxapine dosage adjustments.